BlueRidge Life Sciences (Renovus-backed) Acquires Design Science

January 23, 2026

BlueRidge Life Sciences, a Renovus Capital Partners portfolio company, has acquired Design Science, a human factors and usability engineering consultancy serving medical device, pharmaceutical, and biotechnology clients. The deal expands BlueRidge's human factors, usability testing, and use-related risk analysis capabilities and will let Design Science continue operating under its existing brand with current leadership.

Buyers
BlueRidge Life Sciences, Renovus Capital Partners
Targets
Design Science
Platforms
BlueRidge Life Sciences
Location
Pennsylvania, United States
Transaction Type
Addon

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.